| ||||||||||||||
|
|
|||||||||||||
Department of Anesthesiology, Shimane Medical University, Izumo, Shimane, Japan
Address correspondence to Y. Saito, MD, Department of Anesthesiology, Shimane Medical University, 89-1 Enya-cho, Izumo, Shimane 693-8501, Japan. Address e-mail to ysaito{at}shimane-med.ac.jp
Previous reports indicate that there may be an interaction between
-aminobutyric acid receptors and opioid receptors systems within the spinal cord, the antinociceptive effects of which have not been elucidated. We examined the effects of intrathecally coadministered morphine and muscimol or baclofen on somatic and visceral antinociception in rats. The tail flick (TF) test and colorectal distension (CD) test were used to assess somatic and visceral antinociceptive effects, respectively. Motor function was also assessed. The measurements were performed for 180 min after the intrathecal administration of morphine (0.110 µg), muscimol (0.210 µg), baclofen (0.031 µg), combination of morphine and muscimol or baclofen, or saline. Morphine, muscimol, or baclofen increased both TF latency and CD threshold in a dose-dependent fashion. Although morphine 0.1 µg, muscimol 0.2 µg, or baclofen 0.03 µg alone did not significantly increase TF latency and CD threshold, the combination of morphine 0.1 µg and muscimol 0.2 µg or baclofen 0.03 µg significantly increased both TF latency and CD threshold. The coadministration of muscimol or baclofen increased the antinociceptive effects of morphine in intensity and duration. None of the rats showed motor dysfunction after the coadministration of morphine and muscimol 0.2 µg, although muscimol produced motor paralysis of the lower limbs in a dose-dependent fashion. Those results suggest a clinical relevance of the coadministration of µ-opioids and GABA receptor agonists for pain control.
Implications: We examined the antinociceptive interaction between morphine and muscimol or baclofen at the spinal level in rats. Intrathecal muscimol or baclofen potentiated both somatic and visceral antinociceptive effects of morphine.
This article has been cited by other articles:
![]() |
K. Hara, Y. Saito, Y. Kirihara, and S. Sakura The Interaction Between Gamma-Aminobutyric Acid Agonists and Diltiazem in Visceral Antinociception in Rats Anesth. Analg., May 1, 2004; 98(5): 1380 - 1384. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-R. Lin, L.-C. Yang, H.-L. You, C.-T. Lee, M.-H. Tai, P.-H. Tan, M.-W. Lin, and J.-T. Cheng Antinociceptive Potentiation and Attenuation of Tolerance by Intrathecal Electric Stimulation in Rats Anesth. Analg., June 1, 2003; 96(6): 1711 - 1716. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. Sengupta, B. K. Medda, and R. Shaker Effect of GABAB receptor agonist on distension-sensitive pelvic nerve afferent fibers innervating rat colon Am J Physiol Gastrointest Liver Physiol, December 1, 2002; 283(6): G1343 - G1351. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nakamura, M. Kakinohana, Y. Taira, H. Iha, and K. Sugahara The Effect of Gamma-Aminobutyric Acid (GABA) Receptor Drugs on Morphine-Induced Spastic Paraparesis After a Noninjurious Interval of Spinal Cord Ischemia in Rats Anesth. Analg., November 1, 2002; 95(5): 1389 - 1395. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Walker, L. C. Goudas, M. J. Cousins, and D. B. Carr Combination Spinal Analgesic Chemotherapy: A Systematic Review Anesth. Analg., September 1, 2002; 95(3): 674 - 715. [Full Text] [PDF] |
||||
![]() |
D. Le Bars, M. Gozariu, and S. W. Cadden Animal Models of Nociception Pharmacol. Rev., December 1, 2001; 53(4): 597 - 652. [Abstract] [Full Text] [PDF] |
||||
|